Unknown

Dataset Information

0

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.


ABSTRACT: Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and malignant mammary stem/progenitor cell populations. We demonstrate that activation of this pathway, via PTEN knockdown, enriches for normal and malignant human mammary stem/progenitor cells in vitro and in vivo. Knockdown of PTEN in normal human mammary epithelial cells enriches for the stem/progenitor cell compartment, generating atypical hyperplastic lesions in humanized NOD/SCID mice. Akt-driven stem/progenitor cell enrichment is mediated by activation of the Wnt/beta-catenin pathway through the phosphorylation of GSK3-beta. In contrast to chemotherapy, the Akt inhibitor perifosine is able to target the tumorigenic cell population in breast tumor xenografts. These studies demonstrate an important role for the PTEN/PI3-K/Akt/beta-catenin pathway in the regulation of normal and malignant stem/progenitor cell populations and suggest that agents that inhibit this pathway are able to effectively target tumorigenic breast cancer cells.

SUBMITTER: Korkaya H 

PROVIDER: S-EPMC2683567 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.

Korkaya Hasan H   Paulson Amanda A   Charafe-Jauffret Emmanuelle E   Ginestier Christophe C   Brown Marty M   Dutcher Julie J   Clouthier Shawn G SG   Wicha Max S MS  

PLoS biology 20090602 6


Recent evidence suggests that many malignancies, including breast cancer, are driven by a cellular subcomponent that displays stem cell-like properties. The protein phosphatase and tensin homolog (PTEN) is inactivated in a wide range of human cancers, an alteration that is associated with a poor prognosis. Because PTEN has been reported to play a role in the maintenance of embryonic and tissue-specific stem cells, we investigated the role of the PTEN/Akt pathway in the regulation of normal and m  ...[more]

Similar Datasets

| S-EPMC1766434 | biostudies-literature
| S-EPMC7975694 | biostudies-literature
| S-EPMC6691275 | biostudies-literature
| S-EPMC11610130 | biostudies-literature
| S-EPMC1891000 | biostudies-literature
| S-EPMC5346734 | biostudies-literature
| S-EPMC7947698 | biostudies-literature
| S-EPMC2930080 | biostudies-literature
| S-EPMC3524373 | biostudies-literature
| S-EPMC3187850 | biostudies-literature